Rating History for ARS Pharmaceuticals Inc (SPRY) by Roth/MKM
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/4/2025 | Kyle Bauser | New Coverage | Buy (N/A) |
30.00 (N/A) |
8.62 (9.06) |
5.1% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/4/2025 | Kyle Bauser | New Coverage | Buy (N/A) |
30.00 (N/A) |
8.62 (9.06) |
5.1% | Details |
![]() |
|||||||